YCCI News

Kudos to the YCCI Recruitment team who were spreading the word about the importance of participating in clinical research at Yale at the 12th annual Free Market & Health Fair just outside the Dixwell Community ​“Q” House. The health fair goal is to educate the New Haven community about health factors that affect underrepresented populations.

In an interview, Yale School of Medicine's Sandra Zaeh, MD, discusses the basics of asthma, different approaches to treating the inflammatory condition, and why controlling asthma is of the utmost importance to asthma physicians and pulmonologists.

Brain activity related to alcohol craving and future heavy drinking is different across sexes, a new study finds, which could have implications for treatment.

More than half of human cancers, called “non-inflamed” or “cold” tumors, are not being effectively infiltrated by the cancer-fighting T cells. Essentially, the soldiers are excluded from the battlefield. Yale Cancer Center researchers want to know why.

Patients with PTSD experience both emotional numbness and hyperreactivity. A new study digs into how these contrasting symptoms are linked.

One of the largest multiomics analyses to date examines hallmarks associated with COVID-19 severity and mortality, and how these factors interact with one another.

For years, Yale School of Medicine's Kasia Lipska, MD, MHS, has been advocating for affordable pricing of insulin, an essential —and sometimes lifesaving—drug for many individuals with diabetes. Now, she is turning her attention to a similar trend of soaring prices among new diabetes and obesity medications.

A collection of recent studies from YSM